CLINICOPATHOLOGIC CORRELATION of RETINAL ANGIOMATOUS PROLIFERATION TREATED with RANIBIZUMAB

Research output: Research - peer-reviewArticle

Abstract

Purpose: To describe histopathologic features of an eye with retinal angiomatous proliferation (RAP) secondary to age-related macular degeneration treated with serial ranibizumab injections and to correlate these findings with spectral domain optical coherence tomography. Methods: Histopathologic features from serial sections through the globe of a 93-year-old man with age-related macular degeneration were studied and compared with spectral domain optical coherence tomography images obtained 7 weeks before his death. Results: The pathologic correlate of ranibizumab-treated RAP was a circumscribed, branching paucicellular vascular complex extending from the inner plexiform layer to Bruch membrane. The histopathologic findings corresponded to an area of hyperreflectivity on spectral domain optical coherence tomography imaging, substantiating the reported tomographic appearance of RAP lesions. A frank anastomosis with choroidal or retinal vasculature was not seen in this treated RAP lesion. There was a lack of retinal pigment epithelium underlying the lesion in an area of retinal pigment epithelium detachment. The elastic portion of Bruch membrane appeared intact. Treatment with ranibizumab over an extended period of time may have been associated with a loss of cellularity of the RAP lesion. Conclusion: In a patient with ARMD extensively treated with ranibizumab, color fundus photography, fluorescein angiography and SD-OCT images of RAP correlated histopathologically with a paucicellular intraretinal vascular complex.

LanguageEnglish (US)
Pages1620-1624
Number of pages5
JournalRetina
Volume37
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Ranibizumab
Optical Coherence Tomography
Bruch Membrane
Retinal Pigment Epithelium
Macular Degeneration
Blood Vessels
Fluorescein Angiography
Photography
Color
Injections
Therapeutics

Keywords

  • age-related macular degeneration
  • anti-VEGF
  • choroidal neovascularization
  • clinicopathologic correlation
  • ranibizumab
  • retinal angiomatous proliferation
  • retinal neovascularization

ASJC Scopus subject areas

  • Ophthalmology

Cite this

CLINICOPATHOLOGIC CORRELATION of RETINAL ANGIOMATOUS PROLIFERATION TREATED with RANIBIZUMAB. / Skalet, Alison H.; Miller, Audra K.; Klein, Michael L.; Lauer, Andreas K.; Wilson, David J.

In: Retina, Vol. 37, No. 8, 01.08.2017, p. 1620-1624.

Research output: Research - peer-reviewArticle

@article{04c5d2d51f1245f9a0f02e1534c10e27,
title = "CLINICOPATHOLOGIC CORRELATION of RETINAL ANGIOMATOUS PROLIFERATION TREATED with RANIBIZUMAB",
abstract = "Purpose: To describe histopathologic features of an eye with retinal angiomatous proliferation (RAP) secondary to age-related macular degeneration treated with serial ranibizumab injections and to correlate these findings with spectral domain optical coherence tomography. Methods: Histopathologic features from serial sections through the globe of a 93-year-old man with age-related macular degeneration were studied and compared with spectral domain optical coherence tomography images obtained 7 weeks before his death. Results: The pathologic correlate of ranibizumab-treated RAP was a circumscribed, branching paucicellular vascular complex extending from the inner plexiform layer to Bruch membrane. The histopathologic findings corresponded to an area of hyperreflectivity on spectral domain optical coherence tomography imaging, substantiating the reported tomographic appearance of RAP lesions. A frank anastomosis with choroidal or retinal vasculature was not seen in this treated RAP lesion. There was a lack of retinal pigment epithelium underlying the lesion in an area of retinal pigment epithelium detachment. The elastic portion of Bruch membrane appeared intact. Treatment with ranibizumab over an extended period of time may have been associated with a loss of cellularity of the RAP lesion. Conclusion: In a patient with ARMD extensively treated with ranibizumab, color fundus photography, fluorescein angiography and SD-OCT images of RAP correlated histopathologically with a paucicellular intraretinal vascular complex.",
keywords = "age-related macular degeneration, anti-VEGF, choroidal neovascularization, clinicopathologic correlation, ranibizumab, retinal angiomatous proliferation, retinal neovascularization",
author = "Skalet, {Alison H.} and Miller, {Audra K.} and Klein, {Michael L.} and Lauer, {Andreas K.} and Wilson, {David J.}",
year = "2017",
month = "8",
doi = "10.1097/IAE.0000000000001672",
volume = "37",
pages = "1620--1624",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - CLINICOPATHOLOGIC CORRELATION of RETINAL ANGIOMATOUS PROLIFERATION TREATED with RANIBIZUMAB

AU - Skalet,Alison H.

AU - Miller,Audra K.

AU - Klein,Michael L.

AU - Lauer,Andreas K.

AU - Wilson,David J.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Purpose: To describe histopathologic features of an eye with retinal angiomatous proliferation (RAP) secondary to age-related macular degeneration treated with serial ranibizumab injections and to correlate these findings with spectral domain optical coherence tomography. Methods: Histopathologic features from serial sections through the globe of a 93-year-old man with age-related macular degeneration were studied and compared with spectral domain optical coherence tomography images obtained 7 weeks before his death. Results: The pathologic correlate of ranibizumab-treated RAP was a circumscribed, branching paucicellular vascular complex extending from the inner plexiform layer to Bruch membrane. The histopathologic findings corresponded to an area of hyperreflectivity on spectral domain optical coherence tomography imaging, substantiating the reported tomographic appearance of RAP lesions. A frank anastomosis with choroidal or retinal vasculature was not seen in this treated RAP lesion. There was a lack of retinal pigment epithelium underlying the lesion in an area of retinal pigment epithelium detachment. The elastic portion of Bruch membrane appeared intact. Treatment with ranibizumab over an extended period of time may have been associated with a loss of cellularity of the RAP lesion. Conclusion: In a patient with ARMD extensively treated with ranibizumab, color fundus photography, fluorescein angiography and SD-OCT images of RAP correlated histopathologically with a paucicellular intraretinal vascular complex.

AB - Purpose: To describe histopathologic features of an eye with retinal angiomatous proliferation (RAP) secondary to age-related macular degeneration treated with serial ranibizumab injections and to correlate these findings with spectral domain optical coherence tomography. Methods: Histopathologic features from serial sections through the globe of a 93-year-old man with age-related macular degeneration were studied and compared with spectral domain optical coherence tomography images obtained 7 weeks before his death. Results: The pathologic correlate of ranibizumab-treated RAP was a circumscribed, branching paucicellular vascular complex extending from the inner plexiform layer to Bruch membrane. The histopathologic findings corresponded to an area of hyperreflectivity on spectral domain optical coherence tomography imaging, substantiating the reported tomographic appearance of RAP lesions. A frank anastomosis with choroidal or retinal vasculature was not seen in this treated RAP lesion. There was a lack of retinal pigment epithelium underlying the lesion in an area of retinal pigment epithelium detachment. The elastic portion of Bruch membrane appeared intact. Treatment with ranibizumab over an extended period of time may have been associated with a loss of cellularity of the RAP lesion. Conclusion: In a patient with ARMD extensively treated with ranibizumab, color fundus photography, fluorescein angiography and SD-OCT images of RAP correlated histopathologically with a paucicellular intraretinal vascular complex.

KW - age-related macular degeneration

KW - anti-VEGF

KW - choroidal neovascularization

KW - clinicopathologic correlation

KW - ranibizumab

KW - retinal angiomatous proliferation

KW - retinal neovascularization

UR - http://www.scopus.com/inward/record.url?scp=85026841059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026841059&partnerID=8YFLogxK

U2 - 10.1097/IAE.0000000000001672

DO - 10.1097/IAE.0000000000001672

M3 - Article

VL - 37

SP - 1620

EP - 1624

JO - Retina

T2 - Retina

JF - Retina

SN - 0275-004X

IS - 8

ER -